INS and type 1 diabetes mellitus: These studies reported the safety and efficacy of co-infusion of insulin-secreting adipose-derived MSCs and bone marrow-derived HSCs in patients with T1D, in which the use of an autologous inoculum appeared to confer better long-term control of hyperglycemia compared to allogenic stem cell transplantation [41].